Related News
Tyler Gallo, PharmD, Receives ABRC Grant on Heparin-induced Thrombocytopenia
Thursday, March 27, 2025
College Hosts Inaugural Phoenix Neuroscience Community Data Blitz
Tuesday, March 11, 2025
MD/PhD Student Receives Fellowship from National Heart, Lung and Blood Institute
Friday, February 28, 2025Tech Trends Post
Stereotaxis this week submitted its EMAGIN 5F catheter and its MAGiC catheters for approval by the U.S. Food and Drug Administration. "The development of the first-ever robotically navigated high-density mapping catheter is a major milestone for the (electrophysiology) field," said Roderick Tung, MD, chief of Cardiology and director of Cardiovascular Clinical Research at the University of Arizona College of Medicine – Phoenix. "Mapping with multi-electrode catheters has taught us so much in both mechanism and therapy for both atrial and ventricular arrhythmias."
About the College
Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated more than 900 physicians, all of whom received exceptional training from nine clinical partners and more than 2,700 diverse faculty members. As the anchor to the Phoenix Bioscience Core, which is projected to have an economic impact of $3.1 billion by 2025, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.